Biological effects of 2-oxoglutarate with particular emphasis on the regulation of protein, mineral and lipid absorption/metabolism, muscle performance, kidney function, bone formation and cancerogenesis, all viewed from a healthy ageing perspective state of the art - Review article

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL.1, 2008, Pages 91-106

  Harrison, A P ^a   Pierzynowski, S G ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LUND UNIVERSITY   (Sweden)

Author keywords

2 oxoglutarate; Alpha keto glutarate (AKG); Artery elasticity; Cancer; Cholesterol; Collagen; Melatonin; Mineral absorption; Muscle; Osteoporoses

Indexed keywords

2 OXOGLUTARIC ACID; AMINO ACID; CALCIUM; LIPID; MELATONIN; MINERAL; PLACEBO; PROTEIN;

AGING; ANTINEOPLASTIC ACTIVITY; BIOLOGICAL ACTIVITY; BONE DENSITY; BONE STRENGTH; BONE STRUCTURE; CARCINOGENESIS; CITRIC ACID CYCLE; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG HALF LIFE; DRUG MECHANISM; GASTROINTESTINAL TRACT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FAILURE; KIDNEY FUNCTION; LIPID ABSORPTION; LIPID METABOLISM; MINERAL METABOLISM; MUSCLE FUNCTION; NONHUMAN; OSSIFICATION; OSTEOPOROSIS; PROTEIN METABOLISM; QUALITY OF LIFE;

AGING; ANIMALS; ANTICARCINOGENIC AGENTS; BODY COMPOSITION; BONE DEVELOPMENT; HUMANS; KETOGLUTARIC ACIDS; KIDNEY; LIPID METABOLISM; MUSCLE, SKELETAL; NEOPLASMS; OSTEOPOROSIS;

EID: 51349147548     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (56)

1. Knapowski K, Wieczorowska-Tobis K, Witowski J. Pathophysiology of ageing. J Physiol Pharmacol 2002; 53: 135-146.
2. Konturek SJ, Konturek PC, Brzozowski T , et al. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J Physiol Pharmacol, 2007; 58 (3): 38-405
3. Booth ML, Macaskill P, Owen N, Oldenburg B, Marcus BH, Bauman A. Population prevalence and correlates of stages of change in physical activity. Health Educ Q 1993; 20: 431-440.
4. Salles N. Basic mechanisms of the aging gastrointestinal tract. Dig Dis 2007; 25: 112-117.
5. Greenwald DA. Ageing, the gastrointestinal tract, and risk of acd-re;ated disease. Am J Med 2004; 117 Suppl 5A: 8S-13S.
6. Christie J, Shepherd NA, Codling BW, Valori RM. Gastric cancer below the age of 55; implications for screening patients with uncomplicated dyspepsia. GUT 1997; 41: 513-517.
7. Rutten EP, Engelen MP, Schols AM, Deutz NE. Skeletal muscle glutamate metabolism in health and disease: state of the art. Curr Opin Clin Nutr Metab Care 2005; 8: 41-51.
8. Vandervoort AA, McComas AJ. Contractile changes in opposing muscles of the human ankle joint with aging. J Appl Physiol 1986; 61: 361-367.
9. Coggan AR, Spina RJ, King DS et al. Skeletal muscle adaptations to endurance training in 70-yr-old men and women. J Appl Physiol 1992; 72: 1780-1786.
10. Lexell J. Ageing and human muscle: observations from Sweden. Can J Appl Physiol 1993; 18: 2-18.
11. Lezza AM, Boffoli D, Sacco S, Cantatore P, Gadaleta MN. Correlation between mitochondrial DNA 4977-bp deletion and respiratory chain enzyme activities in aging human skeletal muscles. Biochem Biophys Res Commun 1994; 205: 772-779.
12. Olin T, Bergström E, Jungvid H, von der Decken A. Effect of dietary keto acids (AKG) on intermediary metabolism of nutrients in Atlantic salmon (Salmo salar) during 17-β-Estradiol-induced vitellogenin synthesis. Acta Agric Scand 1992; 42: 246-253.
13. Wernerman J, Hammarqvist F, Vinnars E. Alpha-ketoglutarate and postoperative muscle catabolism. Lancet 1990; 335: 701-703.
14. Junghans P, Demo M, Pierzynowski S, Hennig U, Souffrant W-B. Utilization of α-ketoglutarate (AKG) in young growing pigs after intra-venous and intra-duodenal administration. The EAAP - Symposium (European Association for Animal Production) on Energy and Protein Metabolism and Nutrition - Rostock-Warnemunde, Germany, September, 2003; pp. 303.
15. Junghans P, Demo M, Pierzynowski S, Hennig U, Eberhard Rudolph P, Souffrant W-B. Intraduodenal infusion of α-ketoglutarate decreases whole body energy expenditure in growing pigs. Clinical Nutr 2006; 25: 489-496.
16. Kristensen NB, Jungvid H, Fernandes JA, Pierzynowski SG. Absorption and metabolism of alpha-ketoglutarate in growing pigs. J Anim Physiol Anim Nutr 2002; 86: 1-7.
17. Lambert BD, Filip R, Stoll B. et al. First-pass metabolism limits the intestinal absorption of enteral a-ketoglutarate in young pigs. J Nutr 2006; 136: 2779-2784.
18. Lambert B, Stoll B, Niinikoski H, Pierzynowski S, Burrin DG. Net portal absorption of enterally fed alpha - ketoglutarate is limited in young pigs. J Nutr 2002; 132: 3383-3386.
19. Windmueller HG, Spaeth AE. Intestinal absorption of glutamine and glutamate from the lumen as compared to glutamine from blood. Arch Biochem Biophys 1975; 171: 662-672.
20. Stoll B, Burrin DG, Henry J, Yu H, Jahoor F, Reeds PJ. Substrate oxidation by the portal drained viscera of fed piglets. Am J Physiol 1999; 277: E168-E175.
21. Matthews DE, Marano MA, Campbell RG. Splanchnic bed utilization of glutamine and glutamic-acid in humans. Am J Physiol 1993; 264: E848-E854.
22. Buddington RK, Pajor A, Buddington KK, Pierzynowski S. Absorption of alpha-ketoglutarate by the gastrointestinal tract of pigs. Comp Biochem Physiol 2004 Part A.138/2: 215-220.
23. Dabek M, Kruszewska D, Filip R. et al. α-Ketoglutarate (AKG) absorption from pig intestine and plasma pharmacokinetics. J Anim Physiol Anim Nutr 2005; 89: 419-426.
24. Dobrowolski PJ, Piersiak T, Surve W. et al. Dietary α-ketoglutarate reduces gastrectomy-evoked loss of calvaria and trabecular bone in female rats. Scand J Gastroent 2008; 43: 551-558.
25. Filip R, Pierzynowski SG. The absorption, tissue distribution and excretion on enteraly administered alpha-ketoglutarate in rats. J Anim Physiol Anim Nutr 2008; 92 (2): 182-189.
26. Tocaj A, Filip R, Lindergard B. et al. Alfa keto glutarate (AKG) inhibit osteoporoses development in postmenopausal women. J Bone Miner Res 2003; 18/2: pp. S267.
27. Radzki RP, Bienko M, Pierzynowski SG.. The effect of dietary alpha-ketoglutarate on blood lipid profile during hypercholesterolemia in rats. Scand J Clin Res 2008; (In press).
28. Radzki RP, Bienko M, Puzio I, Filip R, Pierzynowski S, Studzinski T The effect of alpha-ketoglutarate (AKG) on mineralization of femur in ovariectomized rats. Acta Orthoped Scand 2002; 73: 52.
29. Welborn JR, Shpun S, Dantzler WH, Wright SH. Effect of α-ketoglutarate on organic anion transport in single rabbit renal proximal tubules. Am J Physiol 1998; 274: (Renal Physiol 43): F165-F174.
30. Kruszewska D. Probiotics and other bioactive nutritional agents stabilizing gut function and limiting Helicobacter pylori colonisation. Wydawnictwo Univ. of Lodz, ISBN 978-83-725-030-5, 2007.
31. Brüggemann DA, Risbo J, Pierzynowski SG, Harrison AP. Muscle contraction and force: the importance of an ancillary network, nutrient supply and waste removal. Int J Mol Sci 2008: (In Press).
32. Jawien J, Nastalek P, Korbut R. Mouse models of experimental atherosclerosis. J Physiol Pharmacol 2004; 55: 503-517.
33. Filip RS, Pierzynowski SG, Lindegard B, Wernerman J, Haratym-Maj A, Podgurniak M. Alpha-ketoglutarate decreases serum levels of C-terminal cross-linking telopeptide of type I collagen (CTX) in postmenopausal women with osteopenia: six-month study. Int J Vit Nutr Res 2007; 77 (2): 89-97.
34. Tatara MR, Pierzynowski SG, Majcher P. et al. Effect of alpha-ketoglutarate (AKG) on mineralization, morphology and mechanical endurance of femur and tibia in turkey. Bull Vet Inst Pulawy 2004; 48: 305-309.
35. Harrison A, Husted S, Sawa-Wojtanowicz B, Tygesen MP, Tatara MR. Alpha-ketoglutarate treatment early in postnatal life improves bone density in lambs at slaughter. Bone 2004; 35: 204-209.
36. Czesnikiewicz M, Konturek SJ, Loster B, Wisniewska G, Majewski S. Melatonin and ist role in oxidative related stress diseases of oral cavity, J Physiol Pharmacol 2007; 58: Suppl 3: : 5-19
37. Capel F, Demaison L, Maskouri F. et al. Calcium overload increases oxidative stress in old rat gastrocnemius muscle. J Physiol Pharmacol 2005; 56: 369-380.
38. Eastell R, Lambert H. Strategies for skeletal health in the elderly. Proc Nutr Soc 2002; 61: 173-180.
39. Moukarzel AA, Goulet O, Salas JS. et al. Growth retardation in children receiving long-term total parenteral nutrition: effects of ornithine alpha-ketoglutarate. Am J Clin Nutr 1994; 60: 408-413.
40. Mohan S. Insulin-like growth factor binding proteins in bone cell regulation. Growth Regul 1993; 3: 67-70.
41. Fleming PJ, Muller NL, Bryan MH, Bryan AC. The effects of abdominal loading on rib cage distortion in premature infants. Pediatrics 1979; 64: 425-428.
42. Hershenson MB, Colin AA, Wohl ME, Stark AR. Changes in the contribution of the rib cage to tidal breathing during infancy. Am Rev Respir Dis 1990; 141: 922-925.
43. Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA 2002; 288: 2793-2796.
44. Zittel T, Zeeb B, Maier G. et al. High prevalence of bone disorders after gastrectomy. Am J Surg 1997a; 174: 431-438.
45. Zittel T, Maier G, Starlinger M, Becker HD. Calcium and bone metabolism after gastrectomy. Chirurg 1997b; 68: 784-788.
46. Konturek PC, Czesnikiewicz M, Bielanski W, Konturek SJ,. Involvement of Helicobacter pylori infection in neuro-hormonal conrol of food intake. J Physiol Pharmacol 2006; 57 Suppl 5: 67-81.
47. Kaczor JJ, Ziolkowski W, Antosiewicz J, Hac S, Tamopolsky MA, Popinigis J. The effect of aging on anaerobic and aerobic enzyme activities in human skeletal muscle. J Gerontol A Biol Sci Med Sci 2006; 61: 339-344.
48. Rutten EP, Engelen MP, Schols AM, Deutz NE. Skeletasl muscle glutamate metabolism in health and disease. State of art. Curr Opin Clin, Nutr, Metab Care 2005; 8:41-51.
49. Cynober L, Lasnier E, le Boucher J, Jardel A, Coudray-Lucas C. Effect of ornithine alpha-ketoglutarate on glutamin pools in burn injury: evidence of component interaction. Intensive Care Med 2007; 33: 538-541.
50. Mackenzie ED, Selak MA, Tenant DA. et al. Cell-permeating (alpha)-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol Cell Biol 2007; 27: 3282-3289.
51. Dakshayani KB, Subramanian P, Manivasagam T, Essa MM. Metabolic normalization of alpha-ketoglutarate against N-nitrosodiethylamine-induced hepatocarcinogenesis in rats. Fundam Clin Pharmacol 2006; 20: 477-480.
52. Brahimi-Horn C, Pouyssegur J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull Cancer 2006; 93: E73-80.
53. Semenza GL. HIF-1 and human disease: One highly involved factor. Genes Dev 2000; 14: 1983-1991.
54. Matsumoto K, Imagawa S, Obara N. et al. 2-Oxoglutarate downregulates expression of vascular endothelial growth factor and erythropoietin through decreasing hypoxia-inducible factor-1α and inhibits angiogenesis. J Cell Physiol 2006; 209: 333-340.
55. Powis G, Kirkpatrick L. Hypoxia inducible factor-1α as a cancer drug target. Mol Cancer Ther 2004; 3: 647-654.
56. Brzana W, Rzeski W, Kandefer.Szerszen M, Pierzynowski SG. Anticancer activity of α-ketoglutarate (AKG). In vitro study. Polish-Ukrainian Weigl Conference Microbiology in the XXI century, Warsaw University of Life Sciences- SGGW, 24-26 September, 2007; p309.